These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7775644)

  • 41. Effect of 5-alpha-reductase inhibition on sex-hormone-binding globulin in elderly men.
    Jaffe A; Matzkin H; Gilad S; Stern N
    Horm Res; 1994; 41(5-6):215-7. PubMed ID: 7525442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigen.
    Geller J
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1552-5. PubMed ID: 1699965
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride.
    Makridakis N; Reichardt JK
    J Mol Endocrinol; 2005 Jun; 34(3):617-23. PubMed ID: 15956333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of sildenafil on nocturnal penile tumescence and rigidity in normal men: randomized, placebo-controlled, crossover study.
    Rochira V; Granata AR; Balestrieri A; Madeo B; Carani C
    J Androl; 2002; 23(4):566-71. PubMed ID: 12065465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.
    Casabé A; Roehrborn CG; Da Pozzo LF; Zepeda S; Henderson RJ; Sorsaburu S; Henneges C; Wong DG; Viktrup L
    J Urol; 2014 Mar; 191(3):727-33. PubMed ID: 24096118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Therapy of androgenetic alopecia with finasteride. What must be considered in consultation and drug prescribing].
    Wolff H; Kunte C
    MMW Fortschr Med; 1999 Sep; 141(37):38-40. PubMed ID: 10897972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of finasteride on serum concentrations of dihydrotestosterone and testosterone in three clinically normal sexually intact adult male dogs.
    Kamolpatana K; Johnston SD; Hardy SK; Castner S
    Am J Vet Res; 1998 Jun; 59(6):762-4. PubMed ID: 9622748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men.
    Rittmaster RS; Lemay A; Zwicker H; Capizzi TP; Winch S; Moore E; Gormley GJ
    J Clin Endocrinol Metab; 1992 Aug; 75(2):484-8. PubMed ID: 1322427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Saturable binding of finasteride to steroid 5alpha-reductase as determinant of nonlinear pharmacokinetics.
    Suzuki R; Satoh H; Ohtani H; Hori S; Sawada Y
    Drug Metab Pharmacokinet; 2010; 25(2):208-13. PubMed ID: 20460827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.
    Fwu CW; Eggers PW; Kirkali Z; McVary KT; Burrows PK; Kusek JW
    J Urol; 2014 Jun; 191(6):1828-34. PubMed ID: 24342143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men.
    Kwan M; Greenleaf WJ; Mann J; Crapo L; Davidson JM
    J Clin Endocrinol Metab; 1983 Sep; 57(3):557-62. PubMed ID: 6874890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients.
    Traish AM; Hassani J; Guay AT; Zitzmann M; Hansen ML
    J Sex Med; 2011 Mar; 8(3):872-84. PubMed ID: 21176115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate.
    Span PN; Völler MC; Smals AG; Sweep FG; Schalken JA; Feneley MR; Kirby RS
    J Urol; 1999 Jan; 161(1):332-7. PubMed ID: 10037433
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of finasteride (Proscar) on hair growth, hair cycle stage, and serum testosterone and dihydrotestosterone in adult male and female stumptail macaques (Macaca arctoides).
    Rhodes L; Harper J; Uno H; Gaito G; Audette-Arruda J; Kurata S; Berman C; Primka R; Pikounis B
    J Clin Endocrinol Metab; 1994 Oct; 79(4):991-6. PubMed ID: 7962310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The 5α-reductase inhibitor finasteride is not associated with alterations in sleep spindles in men referred for polysomnography.
    Goldstein MR; Cook JD; Plante DT
    Hum Psychopharmacol; 2016 Jan; 31(1):70-4. PubMed ID: 26494125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal male range.
    Buena F; Swerdloff RS; Steiner BS; Lutchmansingh P; Peterson MA; Pandian MR; Galmarini M; Bhasin S
    Fertil Steril; 1993 May; 59(5):1118-23. PubMed ID: 8486184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hormonal effects, tolerability, and preliminary kinetics in men of MK-906, a 5 alpha-reductase inhibitor.
    De Schepper PJ; Imperato-McGinley J; Van Hecken A; De Lepeleire I; Buntinx A; Carlin J; Gressi MH; Stoner E
    Steroids; 1991 Sep; 56(9):469-71. PubMed ID: 1666698
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics and biochemical efficacy after single and multiple oral administration of N-(2-methyl-2-propyl)-3-oxo-4-aza-5 alpha-androst-1-ene-17 beta-carboxamide, a new type of specific competitive inhibitor of testosterone 5 alpha-reductase, in volunteers.
    Ohtawa M; Morikawa H; Shimazaki J
    Eur J Drug Metab Pharmacokinet; 1991; 16(1):15-21. PubMed ID: 1657611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma androsterone/epiandrosterone sulfates as markers of 5 alpha-reductase activity: effect of finasteride in normal men.
    Lewis JG; George PM; Elder PA
    Steroids; 1997; 62(8-9):632-5. PubMed ID: 9292937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome.
    Baas WR; Butcher MJ; Lwin A; Holland B; Herberts M; Clemons J; Delfino K; Althof S; Kohler TS; McVary KT
    Urology; 2018 Oct; 120():143-149. PubMed ID: 29960004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.